BMRA | tickerfilter.com

Fundamental analysis

19%

Profitability 8%

Dept financing 8%

Liquidity 75%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.42%

1 Month

-11.52%

3 Months

-22.74%

6 Months

-34.02%

1 Year

214.03%

2 Year

76.15%

Key data

Stock price

$1.92

P/E Ratio

0.00

DAY RANGE

$1.87 - $1.95

EPS

-$0.57

52 WEEK RANGE

$0.40 - $4.60

52 WEEK CHANGE

$214.03

MARKET CAP

6.802 M

YIELD

N/A

SHARES OUTSTANDING

3.020 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-27-2025

BETA

2.12

PUBLIC FLOAT

AVERAGE 10 VOLUME

$20,315

AVERAGE 30 VOLUME

$16,270

Company detail

CEO: Zackary S. Irani
Region: US
Website: biomerica.com
Employees: 60
IPO year: 2007

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests.

BMRA - BIOMERICA INC